Molecular angiogenesis

被引：220

作者：

Klagsbrun, M ^{[1
]}

Moses, MA

机构：

[1] Childrens Hosp, Dept Surg, Boston, MA 02115 USA

[2] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA

[3] Harvard Univ, Sch Med, Boston, MA 02115 USA

来源：

CHEMISTRY & BIOLOGY | 1999年 / 6卷 / 08期

关键词：

D O I：

10.1016/S1074-5521(99)80081-7

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

New insights into the mechanisms by which blood vessels develop (angiogenesis) have been gained recently, primarily by the identification of factors that inhibit and promote this process. Angiogenesis-stimulating factors are being used to promote growth of new blood vessels in ischemic disease. In contrast, anti-angiogenesis factors are being used as inhibitors of neovascularization to control tumor growth and metastasis.

引用

收藏

页码：R217 / R224

页数：8

相关论文

共 70 条

[1] Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate [J].

Adamis, AP ;

Shima, DT ;

Tolentino, MJ ;

Gragoudas, ES ;

Ferrara, N ;

Folkman, J ;

DAmore, PA ;

Miller, JW .

ARCHIVES OF OPHTHALMOLOGY, 1996, 114 (01) :66-71

[2] Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis [J].

Adams, RH ;

Wilkinson, GA ;

Weiss, C ;

Diella, F ;

Gale, NW ;

Deutsch, U ;

Risau, W ;

Klein, R .

GENES & DEVELOPMENT, 1999, 13 (03) :295-306

[3] SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS [J].

AIELLO, LP ;

PIERCE, EA ;

FOLEY, ED ;

TAKAGI, H ;

CHEN, H ;

RIDDLE, L ;

FERRARA, N ;

KING, GL ;

SMITH, LEH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10457-10461

[4] Isolation of putative progenitor endothelial cells for angiogenesis [J].

Asahara, T ;

Murohara, T ;

Sullivan, A ;

Silver, M ;

vanderZee, R ;

Li, T ;

Witzenbichler, B ;

Schatteman, G ;

Isner, JM .

SCIENCE, 1997, 275 (5302) :964-967

[5] Vascular development: Cellular and molecular regulation [J].

Beck, L ;

DAmore, PA .

FASEB JOURNAL, 1997, 11 (05) :365-373

[6]

Benjamin LE, 1998, DEVELOPMENT, V125, P1591

[7] Effects of angiogenesis inhibitors on multistage carcinogenesis in mice [J].

Bergers, G ;

Javaherian, K ;

Lo, KM ;

Folkman, J ;

Hanahan, D .

SCIENCE, 1999, 284 (5415) :808-812

[8] Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].

Boehm, T ;

Folkman, J ;

Browder, T ;

OReilly, MS .

NATURE, 1997, 390 (6658) :404-407

[9] Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity [J].

Brooks, PC ;

Silletti, S ;

von Schalscha, TL ;

Friedlander, M ;

Cheresh, DA .

CELL, 1998, 92 (03) :391-400

[10] INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].

BROOKS, PC ;

MONTGOMERY, AMP ;

ROSENFELD, M ;

REISFELD, RA ;

HU, TH ;

KLIER, G ;

CHERESH, DA .

CELL, 1994, 79 (07) :1157-1164

← 1 2 3 4 5 6 7 →